Avoid common mistakes on your manuscript.
The authors would like to thank Dr. Sarrah Idrees and Dr. Sabaretnam Mayilvaganan for their kind interests to our article and responding with this letter.
-
1.
In our study, we reanalyzed the relationship between gender-specific multifocality and central compartment lymph-node (CCLN) metastasis. We found that central compartment lymph-node metastasis was more common in female gender-specific multifocality than male gender, but no statistically significant difference was found.
-
2.
On this important question, the pathology reports were re-examined. Aggressive subtype rates of PTC cases: Diffuse sclerosing variant was found in 5.4%, tall cell variant in 7.3%, and solid variants in 2.3%. Statistical analysis to associate these aggressive subtypes of papillary thyroid cancer with multifocality and central lymph-node metastasis did not find a significant association.
-
3.
Eighteen of 52 patients with Papillary Thyroid Microcarcinoma (PTMC) underwent prophylactic CCLN dissection, and the proportion of PTMC patients with CCLN metastases was 25%.
Data availability
The data that support the findings of this study are available on request from the corresponding author.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Informed consent
Informed consent was obtained from all patients for inclusion in the study.
Ethical approval
This study was approved by the Faculty of Medicine, Sakarya University Ethics Committee.
Research involving human participants and/or animals
This study was performed in line with the principles of the Declaration of Helsinki.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ozdemir, K., Kocer, B. & Bayhan, Z. Reply to the editor: should multifocality be an indication for prophylactic neck dissection for papillary thyroid cancer?. Updates Surg 75, 2421 (2023). https://doi.org/10.1007/s13304-023-01645-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-023-01645-x